Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Free Cash Flow (2019 - 2025)

Keros Therapeutics filings provide 7 years of Free Cash Flow readings, the most recent being -$25.9 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 44.1% to -$25.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $107.5 million, a 166.03% increase, with the full-year FY2025 number at $107.5 million, up 166.03% from a year prior.
  • Free Cash Flow hit -$25.9 million in Q4 2025 for Keros Therapeutics, down from $1.8 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $160.6 million in Q1 2025 to a low of -$46.3 million in Q4 2024.
  • Median Free Cash Flow over the past 5 years was -$25.2 million (2022), compared with a mean of -$15.7 million.
  • Biggest five-year swings in Free Cash Flow: crashed 2162.62% in 2023 and later surged 458.58% in 2025.
  • Keros Therapeutics' Free Cash Flow stood at -$19.7 million in 2021, then dropped by 14.94% to -$22.7 million in 2022, then fell by 14.68% to -$26.0 million in 2023, then tumbled by 78.08% to -$46.3 million in 2024, then skyrocketed by 44.1% to -$25.9 million in 2025.
  • The last three reported values for Free Cash Flow were -$25.9 million (Q4 2025), $1.8 million (Q3 2025), and -$29.1 million (Q2 2025) per Business Quant data.